The drug development process is a collaborative effort among scientists, patients, industry sponsors, the FDA and healthcare providers. The primer, linked below, provides an overview of the FDA drug development process, highlighting the rapid advancements in therapeutics, vaccines and testing, and the role of the FDA in ensuring standardization, reproducibility and meeting benchmarks of safety and efficacy.
Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.